nach oben

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Erschienen in:

01.06.2016 | Pulmonale Hypertonie | CME

Therapie des akuten und chronischen Rechtsherzversagens

verfasst von: T. Kramm, S. Guth, C. B. Wiedenroth, H. A. Ghofrani, E. Mayer

Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Ein akutes oder chronisches Rechtsherzversagen wird als Ursache einer kardiopulmonalen Insuffizienz häufig nicht oder zu spät diagnostiziert. Neben klinischen Symptomen und laborchemischen Parametern sind v. a. Echokardiographie und invasive Messungen der Hämodynamik im Rechtsherzkatheter für Diagnose und Therapiekontrolle entscheidend. In der Akutsituation ist zunächst eine symptomatische Therapie des vital bedrohlichen Zustands notwendig. Hauptziele sind die Optimierung der Koronarperfusion und damit der myokardialen Sauerstoffversorgung sowie die Nachlastsenkung des rechten Ventrikels. Bei anhaltendem Rechtsherzversagen kommen zunehmend passagere, extrakorporale oder implantierbare intrakorporale Organersatzverfahren zum Einsatz. Prognostisch entscheidend ist die zielgerichtete Therapie der auslösenden Grunderkrankung.

Haddad F, Hunt SA, Rosenthal DN et al (2008) Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 117:1436–1448CrossRefPubMed

Voelkel NF, Quaife RA, Leinwand LA et al (2006) Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 114:1883–1891CrossRefPubMed

Molaug M, Geiran O, Stokland O et al (1982) Dynamics of the interventricular septum and free ventricular walls during blood volume expansion and selective right ventricular volume loading in dogs. Acta Physiol Scand 116:245–256CrossRefPubMed

Urabe Y, Tomoike H, Ohzono K et al (1985) Role of afterload in determining regional right ventricular performance during coronary underperfusion in dogs. Circ Res 57:96–104CrossRefPubMed

Galie N, Humbert M, Vachiery JL et al (2015) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT. Eur Heart J 37(1):67–119. doi:10.1093/eurheartj/ehv317CrossRefPubMed

Mcintyre KM, Sasahara AA (1971) The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 28:288–294CrossRefPubMed

Haddad F, Doyle R, Murphy DJ et al (2008) Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 117:1717–1731CrossRefPubMed

Vlahakes GJ, Turley K, Hoffman JI (1981) The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 63:87–95CrossRefPubMed

Armour JA, Lippincott DB, Randall WC (1973) Functional anatomy of the interventricular septum. Cardiology 58:65–79CrossRefPubMed

10.

Paden ML, Conrad SA, Rycus PT et al (2013) Extracorporeal Life Support Organization Registry Report 2012. ASAIO J 59:202–210CrossRefPubMed

11.

Bogaard HJ, Abe K, Vonk Noordegraaf A et al (2009) The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 135:794–804CrossRefPubMed

12.

Chan CM, Klinger JR (2008) The right ventricle in sepsis. Clin Chest Med 29:661–676CrossRefPubMed

13.

Denault AY, Couture P, Beaulieu Y et al (2015) Right ventricular depression after cardiopulmonary bypass for valvular surgery. J Cardiothorac Vasc Anesth 29:836–844CrossRefPubMed

14.

Kowalewski J, Brocki M, Dryjanski T et al (1999) Right ventricular morphology and function after pulmonary resection. Eur J Cardiothorac Surg 15:444–448CrossRefPubMed

15.

Aymard T, Kadner A, Widmer A et al (2013) Massive pulmonary embolism: surgical embolectomy versus thrombolytic therapy – should surgical indications be revisited? Eur J Cardiothorac Surg 43:90–94 (discussion 94)CrossRefPubMed

16.

Benza RL, Miller DP, Gomberg-Maitland M et al (2010) Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 122:164–172CrossRefPubMed

17.

Sztrymf B, Souza R, Bertoletti L et al (2010) Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. Eur Respir J 35:1286–1293CrossRefPubMed

18.

Ravelli F, Mase M, Del Greco M et al (2011) Acute atrial dilatation slows conduction and increases AF vulnerability in the human atrium. J Cardiovasc Electrophysiol 22:394–401CrossRefPubMed

19.

Tongers J, Schwerdtfeger B, Klein G et al (2007) Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 153:127–132CrossRefPubMed

20.

Niebauer J, Volk HD, Kemp M et al (1999) Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353:1838–1842CrossRefPubMed

21.

Pilkington SA, Taboada D, Martinez G (2015) Pulmonary hypertension and its management in patients undergoing non-cardiac surgery. Anaesthesia 70:56–70CrossRefPubMed

22.

Fisher MR, Forfia PR, Chamera E et al (2009) Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 179:615–621CrossRefPubMedPubMedCentral

23.

Forfia PR, Fisher MR, Mathai SC et al (2006) Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 174:1034–1041CrossRefPubMed

24.

Meyer M, Haubenreisser H, Sudarski S et al (2015) Where do we stand? Functional imaging in acute and chronic pulmonary embolism with state-of-the-art CT. Eur J Radiol 84:2432–2437CrossRefPubMed

25.

Hoeper MM, Barbera JA, Channick RN et al (2009) Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol 54:S85–96CrossRefPubMed

26.

Hoeper MM, Granton J (2011) Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med 184:1114–1124CrossRefPubMed

27.

Costanzo MR, Guglin ME, Saltzberg MT et al (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49:675–683CrossRefPubMed

28.

Vieillard-Baron A, Charron C, Caille V et al (2007) Prone positioning unloads the right ventricle in severe ARDS. Chest 132:1440–1446CrossRefPubMed

29.

The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRef

30.

Zamanian RT, Haddad F, Doyle RL et al (2007) Management strategies for patients with pulmonary hypertension in the intensive care unit. Crit Care Med 35:2037–2050CrossRefPubMed

31.

Badesch DB, Abman SH, Ahearn GS et al (2004) Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126:35S–62SCrossRefPubMed

32.

Pascual JM, Fiorelli AI, Bellotti GM et al (1990) Prostacyclin in the management of pulmonary hypertension after heart transplantation. J Heart Transplant 9:644–651PubMed

33.

Christenson J, Lavoie A, O’connor M et al (2000) The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med 161:1443–1449CrossRefPubMed

34.

Khan TA, Schnickel G, Ross D et al (2009) A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. J Thorac Cardiovasc Surg 138:1417–1424CrossRefPubMed

35.

Rex S, Missant C, Claus P et al (2008) Effects of inhaled iloprost on right ventricular contractility, right ventriculo-vascular coupling and ventricular interdependence: a randomized placebo-controlled trial in an experimental model of acute pulmonary hypertension. Crit Care 12:R113CrossRefPubMedPubMedCentral

36.

Lepore JJ, Maroo A, Pereira NL et al (2002) Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. Am J Cardiol 90:677–680CrossRefPubMed

37.

Sebkhi A, Strange JW, Phillips SC et al (2003) Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension. Circulation 107:3230–3235CrossRefPubMed

38.

Voswinckel R, Reichenberger F, Enke B et al (2008) Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension. Pulm Pharmacol Ther 21:824–832CrossRefPubMed

39.

Leather HA, Segers P, Berends N et al (2002) Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension. Crit Care Med 30:2548–2552CrossRefPubMed

40.

Kerbaul F, Rondelet B, Demester JP et al (2006) Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med 34:2814–2819CrossRefPubMed

41.

Khazin V, Kaufman Y, Zabeeda D et al (2004) Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children. J Cardiothorac Vasc Anesth 18:156–159CrossRefPubMed

42.

Missant C, Rex S, Segers P et al (2007) Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction. Crit Care Med 35:707–715CrossRefPubMed

43.

Malekan R, Saunders PC, Yu CJ et al (2012) Peripheral extracorporeal membrane oxygenation: comprehensive therapy for high-risk massive pulmonary embolism. Ann Thorac Surg 94:104–108CrossRefPubMed

44.

Fuehner T, Kuehn C, Hadem J et al (2012) Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 185:763–768CrossRefPubMed

45.

Matthews JC, Koelling TM, Pagani FD et al (2008) The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 51:2163–2172CrossRefPubMedPubMedCentral

46.

Berman M, Tsui S, Vuylsteke A et al (2008) Life-threatening right ventricular failure in pulmonary hypertension: RVAD or ECMO? J Heart Lung Transplant 27:1188–1189CrossRefPubMed

47.

Galie N, Corris PA, Frost A et al (2013) Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol 62:D60–D72CrossRefPubMed

48.

Handoko ML, De Man FS, Happe CM et al (2009) Opposite effects of training in rats with stable and progressive pulmonary hypertension. Circulation 120:42–49CrossRefPubMed

49.

Yuan P, Yuan XT, Sun XY et al (2015) Exercise training for pulmonary hypertension: a systematic review and meta-analysis. Int J Cardiol 178:142–146CrossRefPubMed

50.

Mereles D, Ehlken N, Kreuscher S et al (2006) Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 114:1482–1489CrossRefPubMed

51.

Grunig E, Ehlken N, Ghofrani A et al (2011) Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration 81:394–401CrossRefPubMed

52.

Ghofrani HA, D’armini AM, Grimminger F et al (2013) Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 369:319–329CrossRefPubMed

53.

Ghofrani HA, Galie N, Grimminger F et al (2013) Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med 369:330–340CrossRefPubMed

54.

Ghofrani HA, Wiedemann R, Rose F et al (2002) Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 136:515–522CrossRefPubMed

55.

Humbert M, Sitbon O, Simonneau G (2004) Treatment of pulmonary arterial hypertension. N Engl J Med 351:1425–1436CrossRefPubMed

56.

Olschewski H, Hoeper MM, Behr J et al (2010) Long-term therapy with inhaled iloprost in patients with pulmonary hypertension. Respir Med 104:731–740CrossRefPubMed

57.

Mubarak KK (2010) A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension. Respir Med 104:9–21CrossRefPubMed

58.

Kitterman N, Poms A, Miller DP et al (2012) Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY(R). Mayo Clin Proc 87:825–834CrossRefPubMedPubMedCentral

59.

White K, Loscalzo J, Chan SY (2012) Holding our breath: The emerging and anticipated roles of microRNA in pulmonary hypertension. Pulm Circ 2:278–290CrossRefPubMedPubMedCentral

60.

Desole S, Velik-Salchner C, Fraedrich G et al (2012) Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension. Heart Lung 41:599–605CrossRefPubMed

61.

Mayer E, Jenkins D, Lindner J et al (2011) Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 141:702–710CrossRefPubMed

62.

Jenkins D (2015) Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension. Eur Respir Rev 24:263–271CrossRefPubMed

63.

Madani MM, Auger WR, Pretorius V et al (2012) Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg 94:97–103 (discussion 103)CrossRefPubMed

64.

Feinstein JA, Goldhaber SZ, Lock JE et al (2001) Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 103:10–13CrossRefPubMed

65.

Kataoka M, Inami T, Hayashida K et al (2012) Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5:756–762CrossRefPubMed

66.

Sugimura K, Fukumoto Y, Miura Y et al (2013) Three-dimensional-optical coherence tomography imaging of chronic thromboembolic pulmonary hypertension. Eur Heart J 34:2121CrossRefPubMed

67.

Inami T, Kataoka M, Shimura N et al (2013) Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv 6:725–736CrossRefPubMed

68.

New International CTEPH Registry (2015) http://www.cteph-association.org. Zugegriffen: 22.12.2015

69.

Matthews JC, Mclaughlin V (2008) Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and management. Curr Cardiol Rev 4:49–59CrossRefPubMedPubMedCentral

Titel: Therapie des akuten und chronischen Rechtsherzversagens
verfasst von: T. Kramm
S. Guth
C. B. Wiedenroth
H. A. Ghofrani
E. Mayer
Publikationsdatum: 01.06.2016
Verlag: Springer Berlin Heidelberg
Schlagwörter: Pulmonale Hypertonie
Pulmonale Hypertonie
ECMO
ECMO
Pulmonale Hypertonie
Pulmonale Hypertonie
Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin / Ausgabe 5/2016
Print ISSN: 2193-6218
Elektronische ISSN: 2193-6226
DOI: https://doi.org/10.1007/s00063-016-0181-9

Neu im Fachgebiet Kardiologie

19.04.2024 | Vorhofflimmern | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Therapie des akuten und chronischen Rechtsherzversagens

Zusammenfassung

Neu im Fachgebiet Kardiologie

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Kardiologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2016

Reanimation 2015 – das sind die neuen Leitlinien

Thrombotische Mikroangiopathien

Hepatorenales Syndrom bei dekompensierter Leberzirrhose

Das posteriore reversible Enzephalopathiesyndrom

Komplexe Fragestellungen bei kritisch Kranken – Syndrome auf der Intensivstation

Hepatokardiale Wechselwirkungen

Neu im Fachgebiet Kardiologie

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Kardiologie